The Effects of Anodal tDCS on Incontinency in Patients with Multiple Sclerosis (MS)
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20201102049234N1
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 30
Women with Definitive Diagnosis of MS with Stable Disease over the Previous 4 Months
Definite MS Diagnosis According to the 2010 Revised McDonald Criteria
Age Is Between 18 and 45 Years
Having Symptoms of Urinary Incontinence
Patients Have Received Stable Pharmacological Therapies for the Past 6 Months
Patient's Expanded disability status scale (EDSS) Score Should Be Less than 6.5
Patients Have the Cognitive Capacity to Complete the Assessment and Treatment Protocol
Minimal Ability to Contract the Pelvic Floor Muscles
To Be Willing to Participate in the Study
History of MS Relapse during Treatment
Being Pregnant or in the First 6 Months Post-Partum
Cesarean Section or Vaginal Delivery within 6 Months Previously to Time of Enrolment
Pelvic Organ Prolapse at Vaginal Examination
Urinary Tract Infection
Having Undergone Surgical Treatment for Urinary Incontinence
Having Undergone Prior Physiotherapy for Urinary Incontinence
The Presence of Any Other Neurological or Kidney Disease
Contraindications of Electrical Stimulation
Declining to Participate in the Study
Inability to Understand and Comply with the Study Procedures
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of urinary incontinence. Timepoint: Before the intervention, 4 and 6 weeks after the start of intervention and one month after the end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form.;Pelvic floor muscle function. Timepoint: Before the intervention, 4 and 6 weeks after the start of intervention and one month after the end of intervention. Method of measurement: ultrasonographic device.
- Secondary Outcome Measures
Name Time Method